Treatment recommendations and strategies for the management of bone and joint infections

Expert Opinion on Pharmacotherapy

Volumn 10, Issue 1, 2009, Pages 35-55

  García Lechuz, Juan ^a   Bouza, Emilio ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Adult osteomyelitis; Hematogenous osteomyelitis; Infection related to hardware material; Postoperative spine infection; Prosthetic joint infection

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; DAPTOMYCIN; FUSIDIC ACID; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; METRONIDAZOLE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; RIFAMPICIN; SULTAMICILLIN; TEICOPLANIN; UNINDEXED DRUG; VANCOMYCIN;

ANEMIA; ANTIBIOTIC SENSITIVITY; ARTHRODESIS; ARTHROPLASTY; BIOFILM; BONE AND JOINT INFECTIONS; BONE DEAD SPACE; BONE DISEASE; BONE MARROW SUPPRESSION; BONE PROSTHESIS; BONE SOFT TISSUE COVERAGE; CANCELLOUS BONE; CHRONIC OSTEOMYELITIS; CLINICAL DECISION MAKING; CLINICAL PROTOCOL; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DEBRIDEMENT; DIAGNOSTIC PROCEDURE; DISEASE DURATION; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EARLY ONSET INFECTION; EXCISION; EXTERNAL FIXATOR; FOLLOW UP; FRACTURE FIXATION; HEMATOGENOUS OSTEOMYELITIS; HUMAN; HYPERBARIC OXYGEN; INFECTION; INFECTION RISK; JOINT PROSTHESIS; LONG BONE; LONG BONE OSTEOMYELITIS; LONG TERM CARE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPEN FRACTURE; ORTHOPEDIC SURGERY; OSTEOMYELITIS; PATHOLOGIST; PATIENT COMPLIANCE; PHYSICIAN; PRACTICE GUIDELINE; PROGNOSIS; PROSPECTIVE STUDY; PROSTHESIS INFECTION; QUALITY OF LIFE; REVIEW; RISK FACTOR; RISK REDUCTION; SPINE; SPONDYLITIS; STAPHYLOCOCCUS INFECTION; SURGEON; SURGICAL TECHNIQUE; THROMBOCYTOPENIA; TRAUMATIC OSTEOMYELITIS; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; VACUUM ASSISTED CLOSURE; WOUND INFECTION; ACUTE DISEASE; BONE INFECTION; CHRONIC DISEASE; INFECTIOUS ARTHRITIS; PROSTHESES AND ORTHOSES;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; ARTHRITIS, INFECTIOUS; ARTHROPLASTY, REPLACEMENT; BONE DISEASES, INFECTIOUS; CHRONIC DISEASE; DEBRIDEMENT; HUMANS; HYPERBARIC OXYGENATION; PROSTHESES AND IMPLANTS; TREATMENT OUTCOME;

EID: 65549155392     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656560802611766     Document Type: Review

References (169)

1. Hass DW, McAndrew MP. Bacterial osteomyelitis in adults: evolving considerations in diagnosis and treatment. Am J Med 1996;101:550-61 • A practical approach from almost the beginning of combined surgical and medical therapy. (Pubitemid 126335977)
2. Laughlin RT, Wright DG, Mader JT, Calhoun JH. Osteomyelitis. Curr Opin Rheumatol 1995;7:315-21 • The first bricks of clinical management in osteomyelitis.
3. Waldvogel FA, Medoff G, Swartz MM. Osteomyelitis: a review of clinical features, therapeutic considerations, and unusual aspects. N Engl J Med 1970;282:198-206 •• A classical review about osteomyelitis and its pathogenesis.
4. Gillespie WJ, Allardyce RA. Mechanisms of bone degradation in infection: a review of current hypotheses. Orthopedics 1990;13:407-410 (Pubitemid 20141725)
5. Lew DP, Waldvogel FA. Osteomyelitis [see comments]. N Engl J Med 1997;336(14):999-1007 • The importance of good vascular supply in bone infections.
6. Mader JT, Ortiz M, Calhoun JH. Update on the diagnosis and management of osteomyelitis. Clin Podiatr Med Surg 1996;13(4):701-24 • A comprehensive review upon the classical Cyerny-Mader classification of long bone osteomyelitis.
7. Li W, Pei F, Huang Q, et al. Treatment of bone defect in hip revision. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2007;24(3):534-537
8. Lai D, Chen CM, Chiu FY, et al. Reconstruction of juxta-articular huge defects of distal femur with vascularized fibular bone graft and Ilizarov's distraction osteogenesis. J Trauma 2007;62:166-73 • A short experience with Ilizarov's technique.
9. Norden C, Gillespie J, Nade S. Infections in Bones and Joints. Cambridge, MA: Blackwell; 1994 • Principles of management of long bones osteomyelitis.
10. Bamberger DM. Osteomyelitis. A commonsense approach to antibiotic and surgical treatment. Postgrad Med 1993;94(5):177-184
11. Patzakis MJ, Zalavras CG, Holtom PD. Open fractures. Current concepts of management. In: Calhoun JH, Mader JT, editors, Musculoskeletal Infections. New York: Marcel Dekker; 2003 . p. 131-147 •• A detailed review about theorical and practical keystones in the management of open fractures.
12. Zalavras CG, Patzakis MJ, Holtom PD, et al. Management of open fractures. In: Ross JJ, editor. Update on Musculoskeletal Infections. Philadelphia: W.B. Saunders; 2005 . p. 915-929 •• A pragmatic review about infected open fractures, risks and trends in infectious management.
13. Handoll H, Huntley J, Madhok R. External fixation versus conservative treatment for distal radial fractures in adults. Cochrane Database Syst Rev 2007;3:CD006194 •• A Cochrane analysis about the benefits of the use of external fixationfor radial fractures. (Pubitemid 351805504)
14. Toh CL, Jupiter JB. The infected nonunion of the tibia. Clin Orthop 1995;315:176-91 • A report of 37 cases of infected nonunion tibial fracture emphasizing the lasting impact in the hard follow-up.
15. Struijs PA, Poolman RW, Bhandari M. Infected nonunion of the long bones. J Orthop Trauma 2007;21(7):507-11 • A systematic review the available evidence on the operative management of infected nonunions of the long bones.
16. Dendrinos GK, Kontos S, Lyritsis E. Use of the Ilizarov technique for treatment of non-union of the tibia associated with infection. J Bone Joint Surg Am 1995;77(6):835-46 • A strong and detailed clinical evidence of Ilizarov external fixation advantages in the treatment of infected nonunions.
17. Green SA. Osteomyelitis. The Ilizarov perspective. Orthop Clin North Am 1991;22(3):515-21 • A deep review of Ilizarov's technique and indications.
18. Green SA, Ripley MJ. Chronic osteomyelitis in pin tracks. J Bone Joint Surg [Am] 1984;66(7):1092-8 • Pin-track osteomyelitis could be a difficult to treat experience involving gramnegative bacteria.
19. Green SA, Moore TA, Spohn PJ. Nonunion of the tibial shaft. Orthopedics 1988;11(8):1149-57 • A vast experience on the management of infected nonunions with a 79% of successful healing.
20. Inan M, Halici M, Ayan I, et al. Treatment of type IIIA open fractures of tibial shaft with Ilizarov external fixator versus unreamed tibial nailing. Arch Orthop Trauma Surg 2007;127(8):617-623 (Pubitemid 47304816)
21. Calhoun JH, Anger DM, Mader J, et al. The Ilizarov technique in the treatment of osteomyelitis. Tex Med 1991;87(12):56-9 • The outstanding 75-case clinical experience with the use of Ilizarov external fixator in bone infection.
22. Calif E, Stein H, Lerner A. The Ilizarov external fixation frame in compression arthrodesis of large, weight bearing joints. Acta Orthop Belg 2004;70(1):51-56 (Pubitemid 38297963)
23. Dendrinos GK, Kontos S, Katsenis D, et al Treatment of high-energy tibial plateau fractures by the Ilizarov circular fixator. J Bone Joint Surg Br 1996;78(5):710-17 • An outstanding review of 24 cases successfully treated with Ilizarov's external fixation.
24. Paley D, Catagni MA, Argnani F, et al. Ilizarov treatment of tibial nonunions with bone loss. Clin Orthop 1989;241:146-165 (Pubitemid 19101252)
25. Saridis A, Panagiotopoulos E, Tyllianakis M, et al. The use of the Ilizarov method as a salvage procedure in infected nonunion of the distal femur with bone loss. J Bone Joint Surg Br 2006;88(2):232-237 (Pubitemid 43279937)
26. Brighton CT, Shaman P, Heppenstall RB, et al. Tibial nonunion treated with direct current, capacitive coupling, or bone graft. Clin Orthop 1995;321:223-234
27. Meadows SE, Zuckerman JD, Koval KJ. Posttraumatic tibial osteomyelitis: diagnosis, classification, and treatment. Bull Hosp Jt Dis 1993;52(2):11-16 (Pubitemid 23086023)
28. Böhm E, Josten C. What's new in exogenous osteomyelitis? Pathol Res Pract 1992;188:254-8 • A clinico-pathological guide about post-traumatic osteomyelitis and chronic outcome.
29. Gosselin RA, Roberts I, Gillespie WJ. Antibiotics for preventing infection in open limb fractures. Cochrane Database Syst Rev 2004;1:CD003764 •• The Cochrane systematic review about the protective use of antibiotics in early infections in open fractures.
30. Anthony JP, Mathes SJ, Alpert BS. The muscle flap in the treatment of chronic lower extremity osteomyelitis: results in patients over 5 years after treatment. Plast Reconstr Surg 1991;88(2):311-18 • Guidelines for muscle-flap selection and treatment techniques in current use are presented.
31. May JW Jr, Jupiter JB, Gallico GG, et al. Treatment of chronic traumatic bone wounds Microvascular free tissue transfer: a 13-year experience in 96 patients. Ann Surg 1991;214(3):241-50; discussion 50-2 •• The Mass General Hospital report is the largest published experience about microvascular free tissue transfers after chronic traumatic bone wounds.
32. May JW Jr, Gallico GG, Lukash FN. Microvascular transfer of free tissue for closure of bone wounds of the distal lower extremity. N Engl J Med 1982;306(5):253-7 •• Strong evidence supporting the use of microvascular transfer of vascularized tissues for closing chronic bone-exposure wounds.
33. Fitzgerald RH Jr, Ruttle PE, Arnold PG, et al. Local muscle flaps in the treatment of chronic osteomyelitis. J Bone Joint Surg [Am] 1985;67(2):175-85 • A large experience on local muscle flaps as wound closure therapy in chronic osteomyelitis.
34. Cierny G, Byrd HS, Jones RE. Primary versus delayed soft tissue coverage for severe open tibial fractures. A comparison of results. Clin Orthop 1983;178:54-63 • A comparison study of wound closure in type III open fractures of the tibia.
35. Cierny G, 3rd. Chronic osteomyelitis. Results of treatment. Instr Course Lect 1990;39:495-508
36. Patzakis MJ, Harvey JPJ, Ivler D. The role of antibiotics in the manangement of open fractures. J Bone Joint Surg 1974;56A:532-41 • One of the first reports about the effect of antibiotics lowering infection rates after open fractures.
37. Seligson D, Henry SL. Treatment of compound fractures. Am J Surg 1991;161(6):693-701
38. Patzakis MJ, Wilkins J, Kumar J, et al. Comparison of the results of bacterial cultures from multiple sites in chronic osteomyelitis of long bones. A prospective study. J Bone Joint Surg Am 1994;76(5):664-6 • The microbiology of traumatic osteomyelitis and recommendation for best culture results.
39. Mader JT, Landon GC, Calhoun J. Antimicrobial treatment of osteomyelitis. Clin Orthop 1993;295:87-95 • A review of primary concepts in antibiotic therapy for osteomyelitis.
40. Gentry LO, Rodriguez-Gómez G. Oral ciprofloxacin compared with parenteral antibiotics in the treatment of osteomyelitis. Antimicrob Agents Chemother 1990;34(1):40-3 • A prospective randomized comparison showing the efficacy of oral ciprofloxacin (vs standard parenteral therapy) in osteomyelitis.
41. Gentry LO. Newer concepts in antimicrobial therapy. Clin Orthop 1990;261:23-26
42. Gentry LO. Prescribing considerations in fluoroquinolone therapy. Pharmacotherapy 1993;13(2 Pt 2):S39-44 • A review of the advantages in the use of quinolone therapy.
43. Rissing JP. Antimicrobial therapy for chronic osteomyelitis in adults: role of the quinolones. Clin Infect Dis 1997;25(6):1327-33 • A review about development and success of antimicrobial therapy for osteomyelitis, focused on quinolones and combination therapy with rifampicin.
44. Galanakis N, Giamarellou H, Moussas T, et al. Chronic osteomyelitis caused by multi-resistant Gram-negative bacteria: evaluation of treatment with newer quinolones after prolonged follow-up. J Antimicrob Chemother 1997;39(2):241-246 (Pubitemid 27116420)
45. Sánchez C, Matamala A, Salavert M, et al. Cotrimoxazole plus rifampicin in the treatment of staphylococcal osteoarticular infection. Enferm Infecc Microbiol Clin 1997;15(1):10-13 (Pubitemid 27094964)
46. Bernard L, Hoffmeyer P, Assal M, et al. Trends in the treatment of orthopaedic prosthetic infections. J Antimicrob Chemother 2004;53(2):127-129 (Pubitemid 38239937)
47. Ensing GT, Neut D, van Horn JR, et al. The combination of ultrasound with antibiotics released from bone cement decreases the viability of planktonic and biofilm bacteria: an in vitro study with clinical strains. J Antimicrob Chemother 2006;58(6):1287-90 • A study of in vitro efficacy of antibiotics and ultrasound combination against biofilm structure.
48. Norden CW, Fierer J, Bryant RE. Chronic staphylococcal osteomyelitis: treatment with regimens containing rifampin. Rev Infect Dis 1983;5(Suppl 3):S495-501
49. Sia IG, Berbari EF, Karchmer AW. Prosthetic joint infections. Infect Dis Clin North Am 2005;19(4):885-914 • A concise revision of prosthetic joint infection treatment.
50. Calhoun JH, Manring MM. Adult osteomyelitis. Infect Dis Clin North Am 2005;19(4):765-86 • A clear review about main commandments in adult osteomyelitis treatment.
51. Rao N, Hamilton CW. Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series. Diagn Microbiol Infect Dis 2007;59(2):173-9 • A clinical case-based experience in the use of linezolid for bone and joint infections.
52. Rao N, Ziran BH, Hall RA, et al. Successful treatment of chronic bone and joint infections with oral linezolid. Clin Orthop Relat Res 2004;427:67-71 (Pubitemid 39362833)
53. Rana B, Butcher I, Grigoris P, et al. Linezolid penetration into osteo-articular tissues. J Antimicrob Chemother 2002;50(5):747-750 (Pubitemid 35331696)
54. Kutscha-Lissberg F, Hebler U, Muhr G, et al. Linezolid penetration into bone and joint tissues infected with methicillin-resistant staphylococci. Antimicrob Agents Chemother 2003;47(12):3964-3966 (Pubitemid 37485016)
55. Falagas ME, Siempos II, Papagelopoulos PJ, et al. Linezolid for the treatment of adults with bone and joint infections. Int J Antimicrob Agents 2007;29(3):233-9 • An update of linezolid experiences in bone and joint infections.
56. Falagas ME, Giannopoulou KP, Ntziora F, Papagelopoulos PJ. Daptomycin for treatment of patients with bone and joint infections: a systematic review of the clinical evidence. Int J Antimicrob Agents 2007;30(3):202-9 • An encouraging review of published reports about daptomycin in bone and joint infections.
57. Finney MS, Crank CW, Segreti J. Use of daptomycin to treat drug-resistant Gram-positive bone and joint infections. Curr Med Res Opin 2005;21(12):1923-6 • A small but promising retrospective review of nine clinical experiences with daptomycin.
58. Rao N, Regalla DM Uncertain efficacy of daptomycin for prosthetic joint infections: a prospective case series. Clin Orthop Relat Res 2006;451:34-37 (Pubitemid 44511305)
59. Jones T, Yeaman MR, Sakoulas G, et al. Failures in clinical treatment of Staphylococcus aureus infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry and, drug binding. Antimicrob Agents Chemother 2008;52(1):269-278
60. Lamp KC, Friedrich LV, Mendez-Vigo L, et al. Clinical experience with daptomycin for the treatment of patients with osteomyelitis. Am J Med 2007;120(10A):S13-20 (Pubitemid 47464123)
61. Stengel D, Bauwens K, Sehouli J, et al. Systematic review and meta-analysis of antibiotic therapy for bone and joint infections. Lancet Infect Dis 2001;1(3):175-88 •• A meta-analysis about trends in antimicrobial therapy for osteomyelitis found in clinical trials performed between 1996 and 2000.
62. Bach MC, Cocchetto DM. Ceftazidime as single-agent therapy for gram-negative aerobic bacillary osteomyelitis. Antimicrob Agents Chemother 1987;31(10):1605-1608 (Pubitemid 17140821)
63. Bouza E, Hellín T, Sanz-Hospital J, et al. Evaluation of ceftazidime in the treatment of severe bacterial infection. J Antimicrob Chemother 1983;12(Suppl A):153-159
64. Jauregui L, Matzke D, Scott M, et al. Cefepime as treatment for osteomyelitis and other severe bacterial infections. J Antimicrob Chemother 1993;32(Suppl B):141-149 (Pubitemid 24025746)
65. Legout L, Senneville E, Stern R, et al. Treatment of bone and joint infections caused by Gram-negative bacilli with a cefepime-fluoroquinolone combination. Clin Microbiol Infect 2006;12(10):1030-1033 (Pubitemid 44322578)
66. Yahav D, Paul M, Fraser A, et al. Efficacy and safety of cefepime: a systematic review and meta-analysis. Lancet Infect Dis 2007;7(5):338-48 • An intriguing meta-analysis of cefepime use and increased mortality compared with other betalactams.
67. Lucht RF, Fresard A, Berthelot P, et al. Prolonged treatment of chronic Pseudomonas aeruginosa osteomyelitis with a combination of two effective antibiotics. Infection 1994;22(4):276-280 (Pubitemid 24255180)
68. Desplaces N, Gutmann L, Carlet J, et al. The new quinolones and their combinations with other agents for therapy of severe infections. J Antimicrob Chemother 1986;17(Suppl A):25-39 (Pubitemid 16143278)
69. Moran E, Masters S, Berendt AR, et al. Guiding empirical antibiotic therapy in orthopaedics: the microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention. J Infect 2007;55(1):1-7 • Retrospective study of 112 cases of prosthetic joint infection treated upon microbiological guide. (Pubitemid 46888074)
70. Graninger W, Wenisch C, Wiesinger E, et al. Experience with outpatient intravenous teicoplanin therapy for chronic osteomyelitis. Eur J Clin Microbiol Infect Dis 1995;14(7):643-647
71. Graninger W, Presterl E, Wenisch C, et al. Management of serious staphylococcal infections in the outpatient setting. Drugs 1997;54(6):21-28 (Pubitemid 28045543)
72. Upton A, Ellis-Pegler RB, Woodhouse A. Outpatient Parenteral Antimicrobial Therapy (OPAT): a review of experience at Auckland Hospital. NZ Med J 2004;117(1200):U1020 • A large experience in the outpatient parenteral antimicrobial therapy for bone and joint infections is described with an 88% success rate.
73. Mader JT, Cantrell JS, Calhoun J. Oral ciprofloxacin compared with standard parenteral antibiotic therapy for chronic osteomyelitis in adults. J Bone Joint Surg [Am] 1990;72(1):104-10 • A clinical trial comparing the efficacy of oral ciprofloxacin versus standard parenteral therapy in osteomyelitis.
74. Lazzarini L, Lipsky BA, Mader JT. Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials? Int J Infect Dis 2005;9(3):127-38 • A large medical literature review from 1968 to 2000 about the optimal agent, duration and route for osteomyelitis treatment with inconclusive results.
75. Gentry LO. Role for newer beta-lactam antibiotics in treatment of osteomyelitis. Am J Med 1985;78(6A):134-9 • Interesting article showing clinical results of betalactam monotherapy in osteomyelitis.
76. Lew DP, Waldvogel FA. Quinolones and osteomyelitis: state-of-the-art. Drugs 1995;49(Suppl 2):100-11 • A critical review of the use of quinolones in osteomyelitis.
77. Romero-Candau FJ, Pérez-Ferri R, Madrigal JM, et al. Treatment of postraumatic osteomyelitis with oral linezolid. Rev Ortop Traumatol (Madr) 2007;51:75-79
78. Vercillo M, Patzakis MJ, Holtom P, et al. Linezolid in the treatment of implant-related chronic osteomyelitis. Clin Orthop Relat Res 2007;461:40-43 (Pubitemid 47344092)
79. Aneziokoro CO, Cannon JP, Pachucki CT, et al. The effectiveness and safety of oral linezolid for the primary and secondary treatment of osteomyelitis. J Chemother 2005;17(6):643-650 (Pubitemid 43097752)
80. Rayner CR, Baddour LM, Birmingham MC, et al. Linezolid in the treatment of osteomyelitis: results of compassionate use experience. Infection 2004;32(1):8-14 (Pubitemid 38210506)
81. Harwood PJ, Talbot C, Dimoutsos M, et al. Early experience with linezolid for infections in orthopaedics. Injury 2006;37(9):818-826 (Pubitemid 44223490)
82. Monsivais JJ. Effective management of osteomyelitis after grade III open fractures. J South Orthop Assoc 1996;5(1):30-36
83. Ostermann PA, Seligson D, Henry SL. Local antibiotic therapy for severe open fractures. A review of 1085 consecutive cases. J Bone Joint Surg Br 1995;77(1):93-7 • A large series of cases reviewed to assess the adjuvant use of aminoglycoside-polymethylmethacrylate beads in compound limb fractures.
84. Adams KR, Couch L, Cierny G, et al. In vitro and in vivo evaluation of antibiotic diffusion from antibiotic-impregnated polymethylmethacrylate beads. Clin Orthop Relat Res 1992;278:244-252
85. Henry SL, Ostermann PA, Seligson D. The prophylactic use of antibiotic impregnated beads in open fractures. J Trauma 1990;30(10):1231-1238 (Pubitemid 20372837)
86. Scott DM, Rotschafer JC, Behrens F. Use of vancomycin and tobramycin polymethylmethacrylate impregnated beads in the management of chronic osteomyelitis. Drug Intell Clin Pharm 1988;22(6):480-483 (Pubitemid 18130233)
87. Wilson KJ, Cierny G, Adams KR, et al. Comparative evaluation of the diffusion of tobramycin and cefotaxime out of antibiotic-impregnated polymethylmethacrylate beads. J Orthop Res 1988;6(2):279-286 (Pubitemid 18104983)
88. Cho SH, Song HR, Koo KH, et al. Antibiotic-impregnated cement beads in the treatment of chronic osteomyelitis. Bull Hosp Jt Dis 1997;56(3):140-144 (Pubitemid 27486178)
89. Moehring HD, Gravel C, Chapmann MW, et al. Comparison of antibiotics beads and intravenous antibiotics in open fractures. Clin Orthop Relat Res 2000;372:254-61 • The study shows higher infection rates in open fractures with antibiotic beads as the only method (8.3%) compared with systemic antibiotics (5.3%).
90. Isefuku S, Joyner CJ, Simpson AH. Toxic effect of rifampicin on human osteoblast-like cells. J Orthop Res 2001;19:950-954 (Pubitemid 32799087)
91. Naal FD, Salzmann GM, von Knoch F, et al. The effects of clindamycin on human osteoblasts in vitro. Arch Orthop Trauma Surg 2008;128(3):317-323
92. Mader JT, Adams KR, Wallace WR, Calhoun JH. Hyperbaric oxygen as adjunctive therapy for osteomyelitis. Infect Dis Clin North Am 1990;4(3):433-40 • A comprehensive review of the use of hyperbaric oxygen.
93. Calhoun JH, Cobos JA, Mader JT. Does hyperbaric oxygen have a place in the treatment of osteomyelitis? Orthop Clin North Am 1991;22(3):467-471
94. Archdeacon MT, Messerschmitt P. Modern papineau technique with vacuum-assisted closure. J Orthop Trauma 2006;20(2):134-137 (Pubitemid 44378181)
95. Torda AJ, Gottlieb T, Bradbury R. Pyogenic vertebral osteomyelitis: analysis of 20 cases and review. Clin Infect Dis 1995;20(2):320-328
96. Bateman JL, Pevzner MM. Spinal osteomyelitis: a review of 10 years' experience. Orthopedics 1995;18(6):561-565
97. Calderone RR, Larsen JM. Overview and classification of spinal infections. Orthop Clin North Am 1996;27(1):1-8 • A review of clinical and epidemiological factors to guide therapy in pyogenic vertebral osteomyelitis.
98. Jensen AG, Espersen F, Skinhoj P, et al. Bacteremic Staphylococcus aureus spondylitis. Arch Intern Med 1998;158(5):509-517 (Pubitemid 128681612)
99. Friedman BC, Simon GL. Candida vertebral osteomyelitis: report of three cases and a review of the literature. Diagn Microbiol Infect Dis 1987;8(1):31-36 (Pubitemid 17164533)
100. Arnold PM, Baek PN, Bernardi RJ, et al. Surgical management of nontuberculous thoracic and lumbar vertebral osteomyelitis: report of 33 cases. Surg Neurol 1997;47(6):551-61 • Surgical indications for vertebral osteomyelitis are analyzed through a series of 33 cases.
101. Ruf M, Stoltze D, Merk HR, et al. Treatment of vertebral osteomyelitis by radical debridement and stabilization using titanium mesh cages. Spine 2007;32(9):E275-80 (Pubitemid 46642564)
102. Grados F, Lescure FX, Senneville E, et al. Suggestions for managing pyogenic (non-tuberculous) discitis in adults. Joint Bone Spine 2007;74(2):133-9 • A literature review (Medline) about diagnosis management and therapy for spondylodiscitis.
103. Berbari EF, Steckelberg JM, Osmon DR, editors, Osteomyelitis 6th edition. London: Churchill Livingstone; 2005 •• Essential book review on the most important topics in osteomyelitis.
104. Karamanis EM, Matthaiou DK, Moraitis LI, et al. Fluoroquinolones versus beta-lactam based regimens for the treatment of osteomyelitis: a meta-analysis of randomized controlled trials. Spine 2008;33(10):E297-304 • The definitive meta-analysis about quinolone use in the treatment of osteomyelitis. (Pubitemid 351630234)
105. Senneville E, Poissy J, Legout L, et al. Safety of prolonged high-dose levofloxacin therapy for bone infections. J Chemother 2007;19(6):688-93 • A clinical experience (84 patients) with the 750-mg or 1-g levofloxacin dose in bone infections.
106. Ortega M, Soriano A, Garcia S, et al. Tolerability and safety of levofloxacinin long-term treatment. Rev Esp Quimioter 2000;13(3):263-266 (Pubitemid 30815285)
107. Lew DP, Waldvogel FA. Use of quinolones in osteomyelitis and infected orthopaedic prosthesis. Drugs 1999;58(Suppl 2):85-91 (Pubitemid 29500093)
108. Ericcson HM, Sherris JC. Antibiotic sensitivity testing: report of an international collaborative study. Acta Pathol Microbiol Scand 1971;227(Suppl B):17
109. Sexton DJ, Heskestad L, Lambeth WR, et al. Postoperative pubic osteomyelitis misdiagnosed as osteitis pubis: report of four cases and review. Clin Infect Dis 1993;17(4):695-700 (Pubitemid 23293381)
110. Lentino JR. Prosthetic joint infections: bane of orthopedists, challenge for infectious disease specialists. Clin Infect Dis 2003;36(9):1157-61 • Keypoints in prosthetic joint infection.
111. Norden CW, Bryant R, Palmer D, et al. Chronic osteomyelitis caused by Staphylococcus aureus: controlled clinical trial of nafcillin therapy and nafcillin-rifampin therapy. South Med J 1986;79(8):947-951
112. Drancourt M, Stein A, Argenson J, et al. Oral rifampin plus ofloxacin for treatment of Staphyloccus-infected orthopedic implants. Antimicrob Agents Chemother 1993;37:1214-1218 (Pubitemid 23166716)
113. Berdal JE, Skramm I, Mowinckel P, et al. Use of rifampicin and ciprofloxacin combination therapy after surgical debridement in the treatment of early manifestation prosthetic joint infections. Clin Microbiol Infect 2005;11(10):843-845 (Pubitemid 41341720)
114. Barberan J. Management of infections of osteoarticular prosthesis. Clin Microbiol Infect 2006;12(Suppl 3):93-101
115. Soriano A, Garcia S, Bori G, et al. Treatment of acute post-surgical infection of joint arthroplasty. Clin Microbiol Infect 2006;12(9):930-3 • A report of clinical success with orally rifampicin combination therapy in acute prosthetic joint infection.
116. Zimmerli W. Infection and musculoskeletal conditions: prosthetic-joint-associated infections. Best Pract Res Clin Rheumatol 2006;20(6):1045-1063
117. Choong PF, Dowsey MM, Carr D, et al. Risk factors associated with acute hip prosthetic joint infections and outcome of treatment with a rifampinbased regimen. Acta Orthop 2007;78(6):755-765 (Pubitemid 351185596)
118. Ariza J, Euba G, Murillo O. Orthopedic device-related infections. Enferm Infecc Microbiol Clin 2008;26(6):380-390 (Pubitemid 351879849)
119. Isiklar ZU, Landon GC, Tullos HS. Amputation after failed total knee arthroplasty. Clin Orthop Relat Res 1994;299:173-178 (Pubitemid 24051717)
120. Coventry MB. Treatment of infections occurring in total hip surgery. Orthop Clin North Am 1975;6(4):991-1003 • A timing approach of hip prosthetic infection and its chronologic pathology.
121. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med 2004;351(16):1645-54 •• Large experience review on diagnosis and treatment options for arthroplasty infection.
122. Widmer AF. New developments in diagnosis and treatment of infection in orthopedic implants. Clin Infect Dis 2001;33(Suppl 2):S94-106 •• A concise review of concepts, risk factors and diagnostic tools and trends on treatment of prosthetic joint infections.
123. Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am 1996;78:521-3 •• Essential report about a new and more practical classification of prosthetic joint infections.
124. Zimmerli W, Widmer AF, Blatter M, et al. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial Foreign-Body Infection (FBI) Study Group. JAMA 1998;279(19):1537-41 •• A randomized, placebo-controlled, double-blind trial conducted from 1992 to 1997 to evaluate the clinical efficacy of a rifampin combination in staphylococcal infections associated with stable orthopedic devices.
125. Marculescu CE, Berbari EF, Hanssen AD, et al. Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis 2006;42(4):471-8 • The Mayo Clinic series of prosthetic joint infection (1995-1999): retrospective results with debridement and retention of the prosthesis.
126. Wilde AH. Management of infected knee and hip prostheses. Curr Opin Rheumatol 1994;6(2):172-176 (Pubitemid 24139874)
127. Waldman BJ, Hostin E, Mont MA, et al. Infected total knee arthroplasty treated by arthroscopic irrigation and debridement. J Arthroplasty 2000;15(4):430-436 (Pubitemid 30413882)
128. Silva M, Tharani R, Schmalzried TP. Results of direct exchange or debridement of the infected total knee arthroplasty. Clin Orthop Relat Res 2002;404:125-131 (Pubitemid 35351061)
129. Vidil A, Beaufils P. Arthroscopic treatment of hematogenous infected total knee arthroplasty: 5 cases. Rev Chir Orthop Reparatrice Appar Mot 2002;88(5):493-500
130. Deirmengian C, Greenbaum J, Lotke PA, et al. Limited success with open debridement and retention of components in the treatment of acute Staphylococcus aureus infections after total knee arthroplast. J Arthroplasty 2003;18(7 Suppl 1):22-26 (Pubitemid 37259661)
131. Klinger HM, Otte S, Baums MH, et al. Infection after arthroscopic treatment of symptomatic total knee arthroplasty. Arthroscopy 2003;19(9):E111-13
132. Hope PG, Kristinsson KG, Norman P, et al. Deep infection of cemented total hip arthroplasties caused by coagulase-negative staphylococci. J Bone Joint Surg Br 1989;71(5):851-855 (Pubitemid 19282581)
133. Ure KJ, Amstutz HC, Nasser S, et al. Direct-exchange arthroplasty for the treatment of infection after total hip replacement. An average ten-year follow-up. J Bone Joint Surg Am 1998;80(7):961-968 (Pubitemid 28355666)
134. Hofmann AA, Kane KR, Tkach TK, et al. Treatment of infected total knee arthroplasty using an articulating spacer. Clin Orthop Relat Res 1995;321:45-54
135. Brandt CM, Duffy MC, Berbari EF, et al. Staphylococcus aureus prosthetic joint infection treated with prosthesis removal and delayed reimplantation arthroplasty. Mayo Clin Proc 1999;74(6):553-8 • Thirty-eight episodes treated with prosthesis removal and delayed reimplantation arthroplasty at Mayo Clinic Rochester between 1980 and 1991 were evaluated.
136. Robbins GM, Masri BA, Garbuz DS, Duncan CP. Primary total hip arthroplasty after infection. Instr Course Lect 2001;50:317-333
137. Mont MA, Waldman BJ, Hungerford DS. Evaluation of preoperative cultures before second-stage reimplantation of a total knee prosthesis complicated by infection. A comparison-group study. J Bone Joint Surg Am 2000;82-A(11):1552-7 • A prospective study and long-term follow-up of 69 surgically grouped cases were done to assess the recurrence rate of infection after two-stage reimplantation.
138. Scharfenberger A, Clark M, Lavoie G, et al. Treatment of an infected total hip replacement with the PROSTALAC system Part 1: infection resolution. Can J Surg 2007;501:24-28
139. Hsieh PH, Chang YH, Chen SH, et al. High concentration and bioactivity of vancomycin and aztreonam eluted from Simplex cement spacers in two-stage revision of infected hip implants: a study of 46 patients at an average follow-up of 107 days. J Orthop Res 2006;24(8):1615-1621 (Pubitemid 44203293)
140. Hanssen AD, Spangehl MJ. Practical applications of antibiotic-loaded bone cement for treatment of infected joint replacements. Clin Orthop Relat Res 2004;427:79-85 (Pubitemid 39362835)
141. Nelson CL. The current status of material used for depot delivery of drugs. Clin Orthop Relat Res 2004;427:72-78 (Pubitemid 39362834)
142. Hart WJ, Jones RS. Two-stage revision of infected total knee replacements using articulating cement spacers and short-term antibiotic therapy. J Bone Joint Surg Br 2006;88(8):1011-1015 (Pubitemid 44241195)
143. Villanueva M, Rios A, Pereiro J. Hand-made articulating spacers for infected total knee arthroplasty: a technical note. Acta Orthop 2006;77(2):329-332
144. Lombardi AV Jr, Karnes JM, Berend KR. A motion maintaining antibiotic delivery system. J Arthroplasty 2007;22(4 Suppl 1):50-55 (Pubitemid 47001308)
145. Thabe H, Schill S. Two-stage reimplantation with an application spacer and combined with delivery of antibiotics in the management of prosthetic joint infection. Oper Orthop Traumatol 2007;19(1):78-100 (Pubitemid 46416287)
146. García-Lechuz JM, Alonso P, García-Arias V, et al. Efficacy of oral antibiotic in prosthetic joint infection: Rifampicin's use revisited. 44th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); Washington (USA); Abstract Book Poster Session K122. ASM Press;Oct. 30-Nov.2 2004:7
147. Lowy FD. Staphylococcus aureus infections. N Engl J Med
148. Levine DP, Fromm BS, Reddy BR. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med 1991;115(9):674-680
149. Davey PG, Rowley DR, Phillips GA. Teicoplanin-home therapy for prosthetic joint infections Eur J Surg Oncol 1992;567(Suppl):23-25
150. Tattevin P, Arvieux C, Michelet C. What is the place of teicoplanin and linezolid in the treatment of prosthetic joint infections? Clin Microbiol Infect 2006;12(12):1241-1242
151. Oussedik SI, Haddad FS. The use of linezolid in the treatment of infected total joint arthroplasty. J Arthroplasty 2008;23(2):273-8 • A retrospective study of 14 patients with a diagnosis of infected total joint arthroplasty treated by 1-or 2-stage revision and a course of oral linezolid.
152. You JH, Lee GC, So RK, et al. Linezolid versus vancomycin for prosthetic joint infections: a cost analysis. Infection 2007;35 (4): 265-270 (Pubitemid 47222284)
153. Trampuz A, Zimmerli W. New strategies for the treatment of infections associated with prosthetic joints. Curr Opin Investig Drugs 2005;6(2):185-190 (Pubitemid 43072957)
154. El Helou OC, Berbari EF, Marculescu CE, et al. Outcome of enterococcal prosthetic joint infection: is combination systemic therapy superior to monotherapy? Clin Infect Dis 2008;47(7):903-909
155. Spinner RJ, Sexton DJ, Goldner RD, et al. Periprosthetic infections due to Mycobacterium tuberculosis in patients with no prior history of tuberculosis. J Arthroplasty 1996;11(2):217-222 (Pubitemid 26070705)
156. Fisman DN, Reilly DT, Karchmer AW, et al. Clinical effectiveness and cost-effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly. Clin Infect Dis 2001;32(3):419-30 • A cost-effectiveness study of exchange arthroplasty versus debridement with prosthesis retention in infected total hip arthroplasy.
157. Stein A, Bataille JF, Drancourt M, et al. Ambulatory treatment of multidrug-resistant Staphylococcus-infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole). Antimicrob Agents Chemother 1998;42(12):3086-91 • A unique prospective study about the use of cotrimoxazole in orthopedic implant infection.
158. Aboltins CA, Page MA, Buising KL, et al. Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid. Clin Microbiol Infect 2007;13(6):586-591 (Pubitemid 46730664)
159. Meehan AM, Osmon DR, Duffy MC, et al. Outcome of penicillin-susceptible streptococcal prosthetic joint infection treated with debridement and retention of the prosthesis. Clin Infect Dis 2003:36(7):845-849 (Pubitemid 36403516)
160. Berbari EF, Osmon DR, Duffy MC, et al. Outcome of prosthetic joint infection in patients with rheumatoid arthritis: the impact of medical and surgical therapy in 200 episodes. Clin Infect Dis 2006;42(2):216-23 • A retrospective study about the outcome of prosthetic joint infection in the cohort of reumatoid patients at Mayo Clinic.
161. Salgado CD, Dash S, Cantey JR, Marculescu CE. Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections. Clin Orthop Relat Res 2007;461:48-53 (Pubitemid 47344093)
162. Kourbatova EV, Halvosa JS, King MD, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections. Am J Infect Control 2005;33(7):385-391 (Pubitemid 41253663)
163. García-Lechuz JM, Alonso P, Alonso JC, et al. A predictive clinical score for prognostic study of prosthetic joint infections 42nd Annual Meeting of the Infectious Diseases Society of America (IDSA); 2004 Sept 30-Oct 3; Boston, USA 2004
164. Patel R, Osmon DR, Hanssen AD. The diagnosis of prosthetic joint infection: current techniques and emerging technologies. Clin Orthop Relat Res 2005;437:55-58 (Pubitemid 41099066)
165. Nilsdotter-Augustinsson A, Briheim G, Herder A, et al. Inflammatory response in 85 patients with loosened hip prostheses A prospective study comparing inflammatory markers in patients with aseptic and septic prosthetic loosening. Acta Orthop 2007;78(5):629-639 (Pubitemid 350034939)
166. Becker W, Palestro CJ, Winship J, et al. Rapid imaging of infections with a monoclonal antibody fragment (LeukoScan). Clin Orthop 1996;329:263-272 (Pubitemid 26274680)
167. Caglar M, Tokgözoglu AM, Ercan MT, et al. The value of Tc-99m citrate scintigraphy in chronic osteomyelitis. An indicator of the involved bone Clin Nucl Med 1995;20 (8): 712-716
168. Sendi P, Rohrbach M, Graber P, et al. Staphylococcus aureus small colony variants in prosthetic joint infection. Clin Infect Dis 2006;43(8):961-967 (Pubitemid 44631093)
169. Cierny G 3rd, Mader JT, Penninck JJ. A clinical staging system for adult osteomyelitis. Clin Orthop Relat Res 2003;414:7-24 .